206 related articles for article (PubMed ID: 35101037)
1. Is metabolic syndrome a risk factor in hepatectomy? A meta-analysis with subgroup analysis for histologically confirmed hepatic manifestations.
Murtha-Lemekhova A; Fuchs J; Feiler S; Schulz E; Teroerde M; Kalkum E; Klotz R; Billeter A; Probst P; Hoffmann K
BMC Med; 2022 Jan; 20(1):47. PubMed ID: 35101037
[TBL] [Abstract][Full Text] [Related]
2. Association of Serum Bilirubin With Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Liang C; Yu Z; Bai L; Hou W; Tang S; Zhang W; Chen X; Hu Z; Duan Z; Zheng S
Front Endocrinol (Lausanne); 2022; 13():869579. PubMed ID: 35937795
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome and hepatic resection: improving outcome.
Agrawal S; Daruwala C
HPB (Oxford); 2011 Dec; 13(12):846-59. PubMed ID: 22081919
[TBL] [Abstract][Full Text] [Related]
4. Complex impacts of gallstone disease on metabolic syndrome and nonalcoholic fatty liver disease.
Lyu J; Lin Q; Fang Z; Xu Z; Liu Z
Front Endocrinol (Lausanne); 2022; 13():1032557. PubMed ID: 36506064
[TBL] [Abstract][Full Text] [Related]
5. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.
Jarvis H; Craig D; Barker R; Spiers G; Stow D; Anstee QM; Hanratty B
PLoS Med; 2020 Apr; 17(4):e1003100. PubMed ID: 32353039
[TBL] [Abstract][Full Text] [Related]
6. Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies.
Marventano S; Salomone F; Godos J; Pluchinotta F; Del Rio D; Mistretta A; Grosso G
Clin Nutr; 2016 Dec; 35(6):1269-1281. PubMed ID: 27060021
[TBL] [Abstract][Full Text] [Related]
7. The association between metabolic risk factors, nonalcoholic fatty liver disease, and the incidence of liver cancer: a nationwide population-based cohort study.
Chen YG; Yang CW; Chung CH; Ho CL; Chen WL; Chien WC
Hepatol Int; 2022 Aug; 16(4):807-816. PubMed ID: 35064545
[TBL] [Abstract][Full Text] [Related]
8. Influence of cytokines, circulating markers and growth factors on liver regeneration and post-hepatectomy liver failure: a systematic review and meta-analysis.
Murtha-Lemekhova A; Fuchs J; Ghamarnejad O; Nikdad M; Probst P; Hoffmann K
Sci Rep; 2021 Jul; 11(1):13739. PubMed ID: 34215781
[TBL] [Abstract][Full Text] [Related]
9. Impact of Metabolic Syndrome on Postoperative Outcomes Among Medicare Beneficiaries Undergoing Hepatectomy.
Paro A; Tsilimigras DI; Dalmacy D; Mirdad RS; Hyer JM; Pawlik TM
J Gastrointest Surg; 2021 Oct; 25(10):2545-2552. PubMed ID: 33547584
[TBL] [Abstract][Full Text] [Related]
10. Association of non-alcoholic fatty liver and metabolic-associated fatty liver with COVID-19 outcomes: A systematic review and meta-analysis.
Jagirdhar GSK; Qasba RK; Pattnaik H; Rama K; Banga A; Reddy ST; Flumignan Bucharles AC; Kashyap R; Elmati PR; Bansal V; Bains Y; DaCosta T; Surani S
World J Gastroenterol; 2023 Jun; 29(21):3362-3378. PubMed ID: 37377589
[TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study.
Pastori D; Sciacqua A; Marcucci R; Del Ben M; Baratta F; Violi F; Pignatelli P;
Intern Emerg Med; 2021 Nov; 16(8):2063-2068. PubMed ID: 33713286
[TBL] [Abstract][Full Text] [Related]
12. Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study.
Kim BJ; Kim HS; Kang JG; Kim BS; Kang JH
J Clin Lipidol; 2016; 10(6):1423-1430.e1. PubMed ID: 27919360
[TBL] [Abstract][Full Text] [Related]
13. The pathologic relevance of metabolic criteria in patients with biopsy-proven nonalcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease: A multicenter cross-sectional study in China.
Yang RX; Zou ZS; Zhong BH; Deng H; He FP; Shi JP; Zhao CY; Mi YQ; Zhou YJ; Di FS; Zheng RD; Du Q; Shang J; Popovic B; Chen J; Fan JG
Hepatobiliary Pancreat Dis Int; 2021 Oct; 20(5):426-432. PubMed ID: 34246549
[TBL] [Abstract][Full Text] [Related]
14. The impact of non-alcoholic fatty liver disease and metabolic syndrome on the progression of coronary artery calcification.
Cho YK; Kang YM; Yoo JH; Lee J; Lee SE; Yang DH; Kang JW; Park JY; Jung CH; Kim HK; Lee WJ
Sci Rep; 2018 Aug; 8(1):12004. PubMed ID: 30104707
[TBL] [Abstract][Full Text] [Related]
15. Metabolic dysfunction-associated fatty liver disease is an early predictor for testosterone deficiency in aging men without metabolic syndrome.
Liu CC; Huang SP; Lee YC; Lee CH; Huang TY; Geng JH; Chang CW; Lin CY; Juan YS; Wu WJ; Hsieh TJ
Front Endocrinol (Lausanne); 2023; 14():1252774. PubMed ID: 37854195
[TBL] [Abstract][Full Text] [Related]
16. Benign Prostatic Hyperplasia, Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: Is Metaflammation the Link?
Russo GI; Cimino S; Castelli T; Favilla V; Gacci M; Carini M; Condorelli RA; La Vignera S; Calogero AE; Motta F; Puzzo L; Caltabiano R; Morgia G
Prostate; 2016 Dec; 76(16):1528-1535. PubMed ID: 27458062
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal cancers in lean individuals with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Souza M; Diaz I; Barchetta I; Mantovani A
Liver Int; 2024 Jan; 44(1):6-14. PubMed ID: 37833849
[TBL] [Abstract][Full Text] [Related]
18. Association of Non-Alcoholic Fatty Liver Disease and Metabolic-Associated Fatty Liver Disease with COVID-19-Related Intensive Care Unit Outcomes: A Systematic Review and Meta-Analysis.
Jagirdhar GSK; Pattnaik H; Banga A; Qasba RK; Rama K; Reddy ST; Bucharles ACF; Kashyap R; Elmati PR; Bansal V; Bains Y; DaCosta T; Surani S
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512051
[No Abstract] [Full Text] [Related]
19. Hepatectomy for Metabolic Associated Fatty Liver Disease (MAFLD) related HCC: Propensity case-matched analysis with viral- and alcohol-related HCC.
Conci S; Cipriani F; Donadon M; Marchitelli I; Ardito F; Famularo S; Perri P; Iaria M; Ansaloni L; Zanello M; La Barba G; Patauner S; Pinotti E; Molfino S; Germani P; Romano M; Sciannamea I; Ferrari C; Manzoni A; Troci A; Fumagalli L; Delvecchio A; Floridi A; Memeo R; Chiarelli M; Crespi M; Zimmitti G; Griseri G; Antonucci A; Zanus G; Tarchi P; Baiocchi GL; Zago M; Frena A; Ercolani G; Jovine E; Maestri M; Valle RD; Grazi GL; Romano F; Giuliante F; Torzilli G; Aldrighetti L; Ruzzenente A;
Eur J Surg Oncol; 2022 Jan; 48(1):103-112. PubMed ID: 34325939
[TBL] [Abstract][Full Text] [Related]
20. Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis.
Ke Y; Liu S; Zhang Z; Hu J
Lipids Health Dis; 2021 May; 20(1):55. PubMed ID: 34034750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
